Upregulation of B1 receptor mediating des-Arg9-BK-induced rat paw oedema by systemic treatment with bacterial endotoxin

British Journal of Pharmacology

Volumn 117, Issue 5, 1996, Pages 793-798

  Campos, Maria M ^a   Souza, Glória E P ^b   Calixto, João B ^a  

^a FEDERAL UNIVERSITY OF SANTA CATARINA   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

B1 and B2 kinin agonists and antagonists; Bacterial endotoxin (LPS); Cycloheximide; Dexamethasone; Inflammatory mediators; Paw oedema (rat)

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; BRADYKININ B1 RECEPTOR; BRADYKININ B1 RECEPTOR AGONIST; BRADYKININ B1 RECEPTOR ANTAGONIST; BRADYKININ B2 RECEPTOR; BRADYKININ DERIVATIVE; CALCITONIN GENE RELATED PEPTIDE; CAPTOPRIL; CYCLOHEXIMIDE; DEXAMETHASONE; ENDOTOXIN; HISTAMINE; INDOMETACIN; PROSTACYCLIN; PROSTAGLANDIN E2; SEROTONIN; SUBSTANCE P; THROMBOCYTE ACTIVATING FACTOR; ANTIINFLAMMATORY AGENT; BRADYKININ; BRADYKININ RECEPTOR; BRADYKININ, DES ARG(9); BRADYKININ, DES-ARG(9)-; DRUG DERIVATIVE; LIPOPOLYSACCHARIDE; PROTEIN SYNTHESIS INHIBITOR;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG INHIBITION; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NONHUMAN; PAW EDEMA; PRIORITY JOURNAL; RAT; RECEPTOR UPREGULATION; SUBCUTANEOUS DRUG ADMINISTRATION; ANIMAL; BIOSYNTHESIS; CHEMICALLY INDUCED DISORDER; COMPARATIVE STUDY; DRUG EFFECT; EDEMA; ESCHERICHIA COLI; HINDLIMB; METABOLISM;

ANIMALS; ANTI-INFLAMMATORY AGENTS; BRADYKININ; CYCLOHEXIMIDE; EDEMA; ESCHERICHIA COLI; HINDLIMB; LIPOPOLYSACCHARIDES; MALE; PROTEIN SYNTHESIS INHIBITORS; RATS; RECEPTOR, BRADYKININ B1; RECEPTORS, BRADYKININ;

EID: 0029658178     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1476-5381.1996.tb15262.x     Document Type: Article

References (51)

1. BATHON, J.M., MANNING, D.C., GOLDMAN, D.W., TOWNS, M.C. & PROUD, D. (1992). Regulation of kinin receptors on human synovial cells and upregulation of receptor number by interleukin-1. J. Pharmacol. Exp. Ther., 260, 384-392.
2. BATHON, J.M. & PROUD, D. (1991). Bradykinin antagonists. Annu. Rev. Pharmacol., 31, 129-162.
3. BHOOLA, K.D., FIGUEROA, C.D. & WORTHY, K. (1992). Biorregulation of kinins: kallikreins, kininogens, and kininases. Pharmacol. Rev., 44, 1-80.
4. BRAIN, S.D. & WILLIAMS, T.J. (1989). Interactions between the tachykinins and calcitonin gene-related peptide lead to the modulation of oedema formation and blood flow in rat skin. Br. J. Pharmacol., 97, 77-82.
5. 9-bradykinin in vitro and in vivo. Br. J. Pharmacol., 92, 257-264.
6. BUCKLEY, T.L., BRAIN, S.D., RAMPART, M. & WILLIAMS, T.J. (1991). Time-dependent synergistic interactions between the vasodilator neuropeptide, calcitonin gene-related peptide (CGRP) and mediators of inflammation. Br. J. Pharmacol., 103, 1515-1519.
7. BURCH, R.M., CONNOR, J.R. & TIFFANY, C.W. (1989). The kallikrein-kininogen-kinin system in chronic inflammation. Agents Actions, 27, 258-260.
8. BURCH, R.M., KYLE, D.J. & STORMENN, T.M. (1993). Molecular Biology and Pharmacology of Bradykinin Receptors, ed. Burch, R.M., p. 107. Austin: R.G. Landes Co.
9. 9-BK and other bradykinin fragments on the synthesis of prostacyclin and the binding by vascular cells in culture. Agents Actions, 24, 224-231.
10. 2 receptors in bradykinin-induced rat paw oedema. Br. J. Pharmacol., 114, 1005-1013.
11. 1 receptors mediating paw oedema and formalin induced-nociception. Modulation by glucocorticoids. Can. J. Physiol. Pharmacol., 61, 329-332.
12. COCKFIELD, S.M., RAMASSAR, V., NOUJAIM, J., VAN DER MEIDE, P.H. & HALLORAN, P.F. (1993). Regulation of IFN-gamma expression in vivo. IFN-gamma up-regulates expression of its mRNA in normal and lipopolysaccharide-stimulated mice. J. Immunol., 150, 717-725.
13. 2 kinin receptors in formalin-induced nociceptive response in the mouse. Br. J. Pharmacol., 110, 193-198.
14. 1 receptors in the maintenance of intra-articular plasma extravasation in chronic antigen-induced arthritis. Br. J. Pharmacol., 113, 940-944.
15. CRUWYS, S.C., KIDD, B.L., MAPP, P.I., WALSH, D.A. & BLAKE, D.R. (1992). The effects of calcitonin gene-related peptide on formation of intra-articular oedema by inflammatory mediators. Br. J. Pharmacol., 107, 116-119.
16. DAMAS, J., BOURDON, V., REMACLE-VOLON, G. & ADAM, A. (1990). Kinins and peritoneal exudates induced by carrageenin and zymosan in rats. Br. J. Pharmacol., 101, 418-422.
17. 9-Bradykinin. Br. J. Pharmacol., 93, 969-977.
18. 9-bradykinin in vivo and in vitro, Immunopharmacol., 17, 187-198.
19. 9-bradykinin: possible role of interleukin-1. Br. J. Pharmacol., 103, 314-315.
20. DRAY, A., PATEL, I.A., PERKINS, M.N. & RUEFF, A. (1992). Bradykinin-induced activation of nociceptors: receptor studies on neonatal rat spinal cord-tail preparation in vitro. Br. J. Pharmacol., 107, 1129-1134.
21. DRAY, A. & PERKINS, M.N. (1993). Bradykinin and inflammatory pain. Trends. Neurosci., 16, 99-104.
22. 1 receptor. Agents Actions, 34, 191-193.
23. 2 production. Br. J. Pharmacol., 113, 389-394.
24. GEIGER, T., ARNOLD, J., RORDORF, C., HENN, R. & VOSBECK, K. (1993). Interferon-gamma overcomes the glucocorticoid-mediated and the interleukin-4-mediated inhibition of interleukin-1 beta synthesis in human monocytes. Lymphokine Cytokine Res., 12, 271-278.
25. HARGREAVES, K.M., TROULLOS, E.S., DIONNE, R.A., SCHMIDT, R.N., SCHAFER, S.C. & JORIS, J.L. (1988). Bradykinin is increased during acute and chronic inflammation: therapeutic implications. Clin. Pharmacol. Ther., 44, 613-621.
26. 2 bradykinin receptors. Mol. Pharmacol., 45, 1-8.
27. 2 receptor. Biochem. Biophys. Res. Commun., 184, 260-268.
28. 6) in fibroblasts stimulated by inflammatory products. Cytokine, 5, 47-56.
29. LERNER, U.H., BRUNIUS, G. & MODEER, T. (1992). On the signal transducing mechanisms involved in the synergistic interaction between interleukin-1 and bradykinin on prostaglandin biosynthesis in human gingival fibroblasts. Biosc. Reports, 12, 263-271.
30. 2 receptor agonists synergistically potentiate interleukin-1-induced prostaglandin biosynthesis in human gingival fibroblasts. Inflammation, 15, 427-436.
31. MARCEAU, F., LUSSIER, A., REGOLI, D. & GIROUD, J.P. (1983). Pharmacology of kinins; their relevance to tissue injury and inflammation. Gen. Pharmacol., 14, 209-229.
32. 9-bradykinin by bacterial endotoxin. Pharmacology, 29, 70-74.
33. 1 type and their antagonists. In Bradykinin Antagonists: Basic and Clinical Research, ed. Burch, R.M., pp. 33-49. New York: Marcel Dekker.
34. MARCEAU, F., ST-PIERRE, S. & REGOLI, D. (1980). Kinin receptors in experimental inflammation. Can. J Physiol. Pharmacol., 58, 536-542.
35. 2 bradykinin receptor. Proc. Natl. Acad. Sci. U.S.A., 88, 7724-7728.
36. 1 bradykinin receptor. J. Biol. Chem., 269, 21583-21586.
37. OCHALSKI, S.J., HARTMAN, D.A., BELFAST, M.T., WALTER, T.L., GLASER, K.B. & CARLSON, R.P. (1993). Inhibition of endotoxin-induced hypothermia and serum TNF-alpha levels in CD-1 mice by various pharmacological agents. Agents Actions, 39, C52-C54.
38. 2 by LPS-stimulated rat bone marrow macrophages after thermal injury: effect of indomethacin. Inflammation, 18, 175-185.
39. PANG, G., COUCH, L., BATEY, R., CLANCY, R. & CRIPPS, A. (1994). GM-CSF, IL-1 alpha, IL-1 beta, IL-6, IL-8, IL-10, ICAM-1 and VCAM-1 gene expression and cytokine production in human duodenal fibroblasts stimulated with lipopolysaccharide, IL-1 alpha and TNF-alpha. Clin. Exp. Immunol., 96, 437-443.
40. 8]-BK and Hoe 140, into two models of persistent hyperalgesia in the rat. Pain, 53, 191-197.
41. 1 receptors 'in vivo' in a model of ultra-violet irradiation-induced thermal hyperalgesia in the rat. Br. J. Pharmacol., 110, 1441-1444.
42. 2 receptor: nucleotide sequence analysis and assignment to chromossome 14. Genomics, 15, 435-438.
43. PROUD, D. & KAPLAN, A.P. (1988). Kinin formation: mechanisms and role in inflammatory disorders. Annu. Rev. Immunol., 6, 49-83.
44. REGOLI, D. & BARABÉ, J. (1980). Pharmacology of bradykinin and related kinins. Pharmacol. Rev., 32, 1-46.
45. REGOLI, D., MARCEAU, F. & BARABÉ, J. (1978). De novo formation of vascular receptors for bradykinin. Can. J. Physiol. Pharmacol., 56, 674-677.
46. 1-receptors for kinins in the rabbit by a bacterial lipopolysaccharide. Eur. J. Pharmacol., 71, 105-119.
47. STERANKA, L.R. & BURCH, R.M. (1991). Bradykinin antagonists in pain and in inflammation. In Bradykinin Antagonists: Basic Clinical Research, ed. Burch, R.M., pp. 171-189. New York: Marcel Dekker.
48. TODA, N., BIAN, K., AKIBA, T. & OKAMURA, T. (1987). Heterogeneity in mechanisms of bradykinin action in canine isolated blood vessels. Eur. J. Pharmacol., 135, 321-329.
49. TIFFANY, C.W. & BURCH, R.M. (1989). Bradykinin stimulates tumor necrosis factor and interleukin 1 release from macrophages. FEBS Lett., 247, 189-192.
50. ULICH, T.R., GUO, K., YIN, S., DEL CASTILLO, J., YI, E.S., THOMPSON, R.C. & EISENBERG, S.P. (1992). Endotoxin-induced gene expression in vivo. Expression of interleukin-1 alpha/beta and interleukin-1 receptor antagonist mRNA during endotoxemia and during endotoxin-initiated local acute inflammation. J. Pathol., 141, 61-68.
51. WHALLEY, E.T., FRITZ, H. & GEIGER, R. (1983). Kinin receptors and angiotensin converting enzyme in rabbit basilar arteries. Naunyn-Schmied. Arch. Pharmacol., 324, 296-391.